Syncor International Posts 83% Gain in Quarter

Syncor International said its earnings rose 83% in its first quarter ended Aug. 31, to $1.1 million, or 10 cents a share. The Sylmar-based company’s sales rose 11%, to $24.9 million.

Syncor, which owns a chain of pharmacies that prepare radioactive drugs, said its pre-tax profit margin climbed to 4.8% in the quarter, up from 2.9% a year before. The company said last year’s earnings were reduced by expenses from its May, 1985, merger with Nuclear Pharmacy.